61 – 70 of 95
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts
(
- Contribution to journal › Article
-
Mark
Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men
(
- Contribution to journal › Article
-
Mark
Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma
(
- Contribution to journal › Article
-
Mark
Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
(
- Contribution to journal › Article
-
Mark
Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH
(
- Contribution to journal › Article
- 2008
-
Mark
Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials
(
- Contribution to journal › Article
-
Mark
Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity.
(
- Contribution to journal › Article
-
Mark
A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome
(
- Contribution to journal › Article
-
Mark
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
(
- Contribution to journal › Article